Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats

Autocrine and Paracrine Function of Angiotensin 1-7 in Tissue Repair During Hypertension

(2014) W. Meng et al.   AMERICAN JOURNAL OF HYPERTENSION

Discrepant Regulation of QT (QTc) Interval Duration by Calcium Channel Blockade and Angiotensin Converting Enzyme Inhibition in Experimental Hypertension

(2014) Jan Klimas et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Angiotensin-(1-7) as a strategy in the treatment of hypertension?

(2014) Daan J.L. van Twist et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Pioglitazone, a PPARγ agonist, provides comparable protection to angiotensin converting enzyme inhibitor ramipril against adriamycin nephropathy in rat

(2014) Peter Ochodnicky et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets

(2014) Fan Jiang et al.   Nature Reviews Cardiology

Vascular Endothelial Growth Factor Inhibitor-Induced Hypertension: From Pathophysiology to Prevention and Treatment Based on Long-Acting Nitric Oxide Donors

(2013) P. Kruzliak et al.   AMERICAN JOURNAL OF HYPERTENSION

Angiotensin-(1–7) Dose-Dependently Inhibits Atherosclerotic Lesion Formation and Enhances Plaque Stability by Targeting Vascular Cells

(2013) Jian Min Yang et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Hypertensive renal disease

(2013) Michael C. Braun et al.   JOURNAL OF HYPERTENSION

Therapeutic potential of nitric oxide donors in the prevention and treatment of angiogenesis-inhibitor-induced hypertension

(2012) Peter Kruzliak et al.   ANGIOGENESIS

The genetic deletion of Mas abolishes salt induced hypertension in mice

(2012) Silvia Heringer-Walther et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The cardiac expression of Mas receptor is responsive to different physiological and pathological stimuli

(2012) Marco Fabricio Dias-Peixoto et al.   PEPTIDES

Regulation of angiotensin-converting enzyme 2 and Mas receptor by Ang-(1–7) in heart and kidney of spontaneously hypertensive rats

(2011) Zhen Tan et al.   JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM

Angiotensin-(1–7) upregulates cardiac nitric oxide synthase in spontaneously hypertensive rats

(2010) María A. Costa et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Vasoprotective and Atheroprotective Effects of Angiotensin (1-7) in Apolipoprotein E–Deficient Mice

(2010) Sonja Tesanovic et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Heart rate correction of the QT duration in rats

(2010) Jana Kmecova et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Telmisartan regresses left ventricular hypertrophy in caveolin-1-deficient mice

(2010) Marta H Krieger et al.   LABORATORY INVESTIGATION

Angiotensin-(1-7) Prevents Cardiomyocyte Pathological Remodeling Through a Nitric Oxide/Guanosine 3′,5′-Cyclic Monophosphate–Dependent Pathway

(2009) Enéas R.M. Gomes et al.   HYPERTENSION

Genetic deletion of the angiotensin-(1–7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria

(2009) Sérgio V.B. Pinheiro et al.   KIDNEY INTERNATIONAL

Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis

(2008) Robson A. S. Santos et al.   EXPERIMENTAL PHYSIOLOGY